Chargement en cours...
Emerging therapies for hemophilia: controversies and unanswered questions
Several new therapies for hemophilia have emerged in recent years. These strategies range from extended half-life factor replacement products and non-factor options with improved pharmacokinetic profiles to gene therapy aiming for phenotypic cure. While these products have the potential to change he...
Enregistré dans:
| Publié dans: | F1000Res |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
F1000 Research Limited
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5931262/ https://ncbi.nlm.nih.gov/pubmed/29770199 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/f1000research.12491.1 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|